Lantheus Holdings, Inc

Day range

$99.80 – $100.09

Open

$99.97

Prev close

$100.10

Volume

877.04K

Market cap

$6.54B

Shares out

65.3M

P/E

23.74

P/S

4.20

P/B

4.98

P/FCF

16.85

ROE

21.0%

ROA

11.4%

Debt/Equity

0.44

Div yield

0.00%

As of Oct 22, 2026

• Legal proceedingsOct 22, 2026

  On October 21, 2026, the Company and Parent each received a request for additional information and documentary materials (each, a "Second Request") from the Federal Trade Commission ("FTC") in connection with the FTC's review of the Merger.

• Shareholder meetingsOct 14, 2026

  A special meeting of stockholders (the "special meeting") of Lantheus Holdings, Inc. ("Lantheus") was held on October 14, 2026. Lantheus stockholders approved the adoption of the Agreement and Plan of Merger, dated as of August 3, 2026, by and among Lantheus, Curium US Holdings LLC and Coco Merger Sub Inc.

• Deal agreementsOct 2, 2026

  On August 3, 2026, Lantheus... entered into an Agreement and Plan of Merger... pursuant to which... Merger Sub will merge with and into the Company... with the Company surviving the Merger as a wholly owned subsidiary of Parent.

• Deal agreementsSep 21, 2026

  As previously disclosed, on August 3, 2026, Lantheus Holdings, Inc. ... entered into an Agreement and Plan of Merger ... pursuant to which ... Merger Sub will merge with and into the Company ... with the Company surviving the Merger as a wholly owned subsidiary of Parent.

• Deal agreementsAug 4, 2026

  On August 3, 2026, Lantheus Holdings, Inc., a Delaware corporation ('Lantheus' or the 'Company'), entered into an Agreement and Plan of Merger (the 'Merger Agreement') by and among the Company, Curium US Holdings LLC, a Delaware limited liability company ('Parent'), and Coco Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ('Merger Sub'), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will merge with and into the Company (the 'Merger'), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

Days to cover

3.6

Short interest

3.78M

Avg volume

1.05M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders
  negativeGlobeNewswire Inc.· Sep 30, 2026
• Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
  positiveGlobeNewswire Inc.· Sep 14, 2026
• Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - SNS Insider
  positiveGlobeNewswire Inc.· Sep 7, 2026
• Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders
  negativeGlobeNewswire Inc.· Aug 4, 2026
• Curium Announces Definitive Agreement to Merge with Lantheus
  positiveGlobeNewswire Inc.· Aug 3, 2026